DUBLIN--(BUSINESS WIRE)--The "Molecular Diagnostics Market by Application, Technology, End User, Product & Service - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%
Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market during the forecast period.
Based on product and service, the molecular diagnostics market is segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents.
The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Molecular Diagnostics Market, By Product & Service
7 Molecular Diagnostics Market, By Technology
8 Molecular Diagnostics Market, By Application
9 Molecular Diagnostics Market, By End User
10 Molecular Diagnostics Market, By Region
11 Competitive Landscape
12 Company Profiles
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company
- Biomrieux Sa
- Danaher Corporation
- Roche Diagnostics
- Siemens AG
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/tljrzj/11_5_bn?w=4